{
    "2018-03-20": [
        [
            {
                "time": "",
                "original_text": "这个板块本轮反弹堪比“独角兽”！价投大旗能否由它扛起？（附股）",
                "features": {
                    "keywords": [
                        "板块",
                        "反弹",
                        "独角兽",
                        "价值投资"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "股市收评：中国“新掌柜”上台 揭开新一页",
                "features": {
                    "keywords": [
                        "股市",
                        "新掌柜",
                        "政策变化"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "整体市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]医药生物行业投资策略：提示多因素驱动下连锁药店的投资机会",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "投资策略",
                        "连锁药店"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "五大券商周三看好6板块44股",
                "features": {
                    "keywords": [
                        "券商",
                        "看好",
                        "板块",
                        "个股"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "多元"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药电商午后拉升 大参林大涨",
                "features": {
                    "keywords": [
                        "医药电商",
                        "拉升",
                        "大参林"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药板块持续拉升 关注景气度高的细分领域龙头",
                "features": {
                    "keywords": [
                        "医药",
                        "拉升",
                        "景气度",
                        "龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药板块政策暖风吹 12股3月以来创历史新高",
                "features": {
                    "keywords": [
                        "医药",
                        "政策",
                        "暖风",
                        "历史新高"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报:顶层机构改革落地 坚守创新和一致性评价",
                "features": {
                    "keywords": [
                        "医药生物",
                        "机构改革",
                        "创新",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业:国务院机构改革开启医药行业“大医保”时代",
                "features": {
                    "keywords": [
                        "医药生物",
                        "国务院",
                        "机构改革",
                        "大医保"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}